Literature DB >> 19748418

Performance characteristics of the Euroimmun enzyme-linked immunosorbent assay kits for Brucella IgG and IgM.

Harry E Prince1, Janice Lopez, Cindy Yeh, Joselita Tablante, Joseph Morgan, Beverly Kaneko, Paul Duffey.   

Abstract

Brucella IgG and IgM ELISA kits manufactured by Euroimmun (Lubeck, Germany) were evaluated in a reference laboratory setting. Intraassay coefficient of variation (CV) values were < or =10% for positive sera and < or =12% for negative sera; interassay CVs were < or =12% for positive sera and < or =20% for negative sera. The tube agglutination test (TAT) was performed on 51 sera exhibiting various ELISA reactivity profiles. All 18 sera negative for both IgG and IgM by ELISA were TAT negative (titer <1:80), whereas 31 (94%) of 33 sera positive for IgG and/or IgM were TAT positive; the 2 discordant sera were IgG positive IgM negative by ELISA. None of 41 sera from healthy laboratory employees were ELISA IgG positive, whereas 1 (2%) of 41 was ELISA IgM positive. Similarly, 0 of 149 potentially cross-reactive sera (containing rheumatoid factor or antibodies to selected Gram-negative bacteria) was ELISA IgG positive, whereas 4 (3%) of 149 were ELISA IgM positive. These findings demonstrate the acceptable performance of the Euroimmun ELISAs for Brucella antibodies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19748418     DOI: 10.1016/j.diagmicrobio.2009.06.002

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  2 in total

1.  A high percentage of serum samples that test reactive by enzyme immunoassay for anti-Brucella antibodies are not confirmed by the standard tube agglutination test.

Authors:  Matthew J Binnicker; Elitza S Theel; Staci M Larsen; Robin Patel
Journal:  Clin Vaccine Immunol       Date:  2012-06-20

2.  Brucella Seroprevalence in a High-Risk Population in Greece: A Cross-Sectional Study.

Authors:  Panagiotis Andriopoulos; Dimitrios Floros; Natalia Gioti; Anargiros Mariolis; Andrea Paola Rojas Gil; Maria Tsironi
Journal:  Interdiscip Perspect Infect Dis       Date:  2018-12-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.